Hohol MJ - Search Results

1

Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden.

Khoury SJ, Guttmann CR, Orav EJ, Hohol MJ, Ahn SS, Hsu L, Kikinis R, Mackin GA, Jolesz FA, Weiner HL. Khoury SJ, et al. Among authors: hohol mj. Neurology. 1994 Nov;44(11):2120-4. doi: 10.1212/wnl.44.11.2120. Neurology. 1994. PMID: 7969970

2

Therapy for multiple sclerosis.

Weiner HL, Hohol MJ, Khoury SJ, Dawson DM, Hafler DA. Weiner HL, et al. Among authors: hohol mj. Neurol Clin. 1995 Feb;13(1):173-96. Neurol Clin. 1995. PMID: 7739502 Review.

3

Disease steps in multiple sclerosis: a simple approach to evaluate disease progression.

Hohol MJ, Orav EJ, Weiner HL. Hohol MJ, et al. Neurology. 1995 Feb;45(2):251-5. doi: 10.1212/wnl.45.2.251. Neurology. 1995. PMID: 7854521

4

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.

Hohol MJ, Guttmann CR, Orav J, Mackin GA, Kikinis R, Khoury SJ, Jolesz FA, Weiner HL. Hohol MJ, et al. Arch Neurol. 1997 Aug;54(8):1018-25. doi: 10.1001/archneur.1997.00550200074013. Arch Neurol. 1997. PMID: 9267977

5

Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.

Hohol MJ, Orav EJ, Weiner HL. Hohol MJ, et al. Mult Scler. 1999 Oct;5(5):349-54. doi: 10.1177/135245859900500508. Mult Scler. 1999. PMID: 10516779

6

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.

Hohol MJ, Olek MJ, Orav EJ, Stazzone L, Hafler DA, Khoury SJ, Dawson DM, Weiner HL. Hohol MJ, et al. Mult Scler. 1999 Dec;5(6):403-9. doi: 10.1177/135245859900500i606. Mult Scler. 1999. PMID: 10618696

7

Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage.

Weiner HL, Guttmann CR, Khoury SJ, Orav EJ, Hohol MJ, Kikinis R, Jolesz FA. Weiner HL, et al. Among authors: hohol mj. J Neuroimmunol. 2000 May 1;104(2):164-73. doi: 10.1016/s0165-5728(99)00273-8. J Neuroimmunol. 2000. PMID: 10713356

8

Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.

Sperling RA, Guttmann CR, Hohol MJ, Warfield SK, Jakab M, Parente M, Diamond EL, Daffner KR, Olek MJ, Orav EJ, Kikinis R, Jolesz FA, Weiner HL. Sperling RA, et al. Among authors: hohol mj. Arch Neurol. 2001 Jan;58(1):115-21. doi: 10.1001/archneur.58.1.115. Arch Neurol. 2001. PMID: 11176944

9

Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.

Hohol MJ, Khoury SJ, Cook SL, Orav EJ, Hafler DA, Weiner HL. Hohol MJ, et al. Ann N Y Acad Sci. 1996 Feb 13;778:243-50. doi: 10.1111/j.1749-6632.1996.tb21132.x. Ann N Y Acad Sci. 1996. PMID: 8610977 Clinical Trial. No abstract available.

10

Methotrexate in the treatment of multiple sclerosis.

Olek MJ, Hohol MJ, Weiner HL. Olek MJ, et al. Among authors: hohol mj. Ann Neurol. 1996 May;39(5):684. doi: 10.1002/ana.410390525. Ann Neurol. 1996. PMID: 8619559 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters